KERX - Keryx Biopharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5771.88M
Enterprise Value 3756.35M
Trailing P/E -3.79
Forward P/E 1-20.31
PEG Ratio (5 yr expected) 1-0.05
Price/Sales (ttm)18.02
Price/Book (mrq)30.09
Enterprise Value/Revenue 317.66
Enterprise Value/EBITDA 6-6.21

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin 0.00%
Operating Margin (ttm)-286.44%
Management Effectiveness
Return on Assets (ttm)-38.74%
Return on Equity (ttm)-432.72%
Income Statement
Revenue (ttm)42.83M
Revenue Per Share (ttm)0.40
Quarterly Revenue Growth (yoy)63.00%
Gross Profit (ttm)-8.71M
EBITDA -121.75M
Net Income Avi to Common (ttm)-184.99M
Diluted EPS (ttm)-1.72
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)140.53M
Total Cash Per Share (mrq)1.18
Total Debt (mrq)125M
Total Debt/Equity (mrq)487.35
Current Ratio (mrq)5.76
Book Value Per Share (mrq)0.22
Cash Flow Statement
Operating Cash Flow (ttm)-88.16M
Levered Free Cash Flow (ttm)-19.12M

Trading Information

Stock Price History
Beta 3.26
52-Week Change 337.15%
S&P500 52-Week Change 319.09%
52 Week High 38.38
52 Week Low 34.11
50-Day Moving Average 37.16
200-Day Moving Average 36.77
Share Statistics
Avg Vol (3 month) 31.18M
Avg Vol (10 day) 31.45M
Shares Outstanding 5118.75M
Float 84.79M
% Held by Insiders 11.32%
% Held by Institutions 167.50%
Shares Short 319.49M
Short Ratio 312.49
Short % of Float 324.25%
Shares Short (prior month) 319.43M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A